Reaction Details Report a problem with these data
Target
Epidermal growth factor receptor [695-1022]
Ligand
BDBM525486
Substrate
n/a
Meas. Tech.
Biochemical EGFR Inhibition Assays (5 mM ATP)
IC50
256±n/a nM
Citation
 Boese, D; Dahmann, G; Engelhardt, H; Petronczki, M; Scharn, D Benzimidazole compounds and derivatives as EGFR inhibitors US Patent  US11174245 Publication Date 11/16/2021 
Target
Name:
Epidermal growth factor receptor [695-1022]
Synonyms:
EGFR | EGFR (aa 695-1022) | EGFR_HUMAN | ERBB | ERBB1 | HER1
Type:
Enzyme Catalytic Domain
Mol. Mass.:
37339.79
Organism:
Homo sapiens (Human)
Description:
P00533[695-1022]
Residue:
328
Sequence:
SGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG
  
Inhibitor
Name:
BDBM525486
Synonyms:
US11174245, # I-136 | US11174245, # I-138
Type:
Small organic molecule
Emp. Form.:
C24H23N7O2
Mol. Mass.:
441.4851
SMILES:
Cn1cc(cn1)-c1cc(cc(n1)C#N)C(=O)\N=c1/[nH]c2ccccc2n1[C@@H]1CC[C@H](O)CC1 |r,wU:26.29,29.33,(5.75,-4.31,;5.75,-2.77,;4.5,-1.87,;4.98,-.4,;6.52,-.4,;6.99,-1.87,;4.21,.93,;2.67,.93,;1.9,2.26,;2.67,3.6,;4.21,3.6,;4.98,2.26,;4.98,4.93,;5.75,6.27,;.36,2.26,;-.41,3.6,;-.41,.93,;-1.95,.93,;-2.86,2.18,;-4.32,1.7,;-5.66,2.47,;-6.99,1.7,;-6.99,.16,;-5.66,-.61,;-4.32,.16,;-2.86,-.32,;-2.46,-1.8,;-3.55,-2.89,;-3.15,-4.38,;-1.66,-4.78,;-1.27,-6.27,;-.57,-3.69,;-.97,-2.2,)|
Structure:
Search PDB for entries with ligand similarity: